Keros TherapeuticsKROS
Close of Friday, October 23, 2026 · Keros Therapeutics is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$11.28
vs its Pivot
-8.0%
OnlyAlpha Score
47
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -2.3% | -44.6% | -27.5% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.01%IWM · 0.01%
Healthcare · Biotech
Get KROS in your free daily emailAfter every close: whether KROS is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track KROS free → Full Stock check
Track KROS free → Full Stock check